Meeting metformin again for the first time
Science Advances · 20.12.2024 · 10 (51)
DOI: 10.1126/sciadv.adu7436 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 20.12.2024. Verfasst von Douglas R Green. Beteiligte Einrichtung: Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38139, USA. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Metformin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
New evidence convincingly shows that metformin, a drug that reduces circulating glucose, acts by inhibiting mitochondrial complex I.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38139, USA.
ORCID-Profile: Douglas R Green
Zitieren
APA
Green, D. R. (2024). Meeting metformin again for the first time. Science Advances, 10(51). https://doi.org/10.1126/sciadv.adu7436
Vancouver
Green DR. Meeting metformin again for the first time. Science Advances. 2024;10(51). doi:10.1126/sciadv.adu7436
BibTeX
@article{Green2024,
author = {Green, Douglas R},
title = {Meeting metformin again for the first time},
journal = {Science Advances},
year = {2024},
volume = {10},
number = {51},
doi = {10.1126/sciadv.adu7436}
}
EUVIMED